Credit Suisse’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$157M Sell
1,747,123
-162,164
-8% -$13.7M 0.15% 117
2023
Q4
$152M Sell
1,909,287
-554,247
-22% -$41.7M 0.15% 124
2023
Q3
$175M Buy
2,463,534
+425,947
+21% +$31.8M 0.18% 104
2023
Q2
$157M Sell
2,037,587
-515,717
-20% -$39.9M 0.16% 112
2023
Q1
$192M Buy
2,553,304
+736,394
+41% +$54.8M 0.19% 95
2022
Q4
$143M Sell
1,816,910
-70,322
-4% -$5.27M 0.15% 132
2022
Q3
$133M Sell
1,887,232
-49,609
-3% -$3.89M 0.15% 138
2022
Q2
$155M Sell
1,936,841
-518,758
-21% -$40.6M 0.16% 115
2022
Q1
$186M Sell
2,455,599
-88,292
-3% -$6.99M 0.16% 126
2021
Q4
$217M Buy
2,543,891
+7,398
+0.3% +$578K 0.12% 166
2021
Q3
$192M Buy
2,536,493
+282,696
+13% +$22.4M 0.11% 179
2021
Q2
$183M Sell
2,253,797
-142,074
-6% -$11.6M 0.1% 202
2021
Q1
$189M Sell
2,395,871
-139,448
-6% -$10.9M 0.1% 227
2020
Q4
$217M Sell
2,535,319
-75,248
-3% -$6.22M 0.11% 197
2020
Q3
$201M Buy
2,610,567
+178,735
+7% +$13.6M 0.12% 167
2020
Q2
$178M Buy
2,431,832
+97,392
+4% +$6.92M 0.13% 149
2020
Q1
$155M Buy
2,334,440
+512,553
+28% +$36.1M 0.13% 130
2019
Q4
$125M Buy
1,821,887
+96,328
+6% +$6.57M 0.09% 221
2019
Q3
$127M Buy
1,725,559
+39,652
+2% +$2.88M 0.11% 177
2019
Q2
$121M Buy
1,685,907
+53,040
+3% +$3.77M 0.11% 176
2019
Q1
$112M Sell
1,632,867
-1,265,805
-44% -$81.8M 0.1% 194
2018
Q4
$173M Buy
2,898,672
+798,894
+38% +$50M 0.18% 96
2018
Q3
$141M Sell
2,099,778
-102,600
-5% -$6.83M 0.13% 147
2018
Q2
$143M Sell
2,202,378
-378,362
-15% -$24.7M 0.14% 126
2018
Q1
$185M Buy
2,580,740
+295,543
+13% +$21.3M 0.17% 106
2017
Q4
$172M Buy
2,285,197
+172,709
+8% +$12.6M 0.15% 116
2017
Q3
$154M Sell
2,112,488
-138,278
-6% -$9.97M 0.15% 125
2017
Q2
$167M Sell
2,250,766
-508,766
-18% -$37.8M 0.16% 110
2017
Q1
$202M Buy
2,759,532
+30,156
+1% +$2.11M 0.18% 101
2016
Q4
$179M Buy
2,729,376
+620,461
+29% +$42.5M 0.18% 100
2016
Q3
$156M Buy
2,108,915
+154,895
+8% +$11.5M 0.15% 121
2016
Q2
$143M Buy
1,954,020
+124,618
+7% +$8.87M 0.16% 120
2016
Q1
$129M Sell
1,829,402
-396,090
-18% -$26.4M 0.16% 126
2015
Q4
$148M Buy
2,225,492
+92,404
+4% +$6.15M 0.17% 121
2015
Q3
$135M Sell
2,133,088
-190,534
-8% -$12.4M 0.16% 119
2015
Q2
$152M Buy
2,323,622
+169,825
+8% +$11.5M 0.15% 142
2015
Q1
$149M Sell
2,153,797
-173,672
-7% -$12M 0.15% 136
2014
Q4
$161M Buy
2,327,469
+69,737
+3% +$4.71M 0.14% 150
2014
Q3
$147M Buy
2,257,732
+133,754
+6% +$8.82M 0.12% 162
2014
Q2
$145M Buy
2,123,978
+389,755
+22% +$26.1M 0.12% 162
2014
Q1
$112M Sell
1,734,223
-178,810
-9% -$11.3M 0.11% 162
2013
Q4
$125M Buy
1,913,033
+205,708
+12% +$13.2M 0.11% 153
2013
Q3
$101M Sell
1,707,325
-1,714,198
-50% -$102M 0.1% 176
2013
Q2
$196M Buy
+3,421,523
New +$203M 0.2% 79

Other funds holding CL

Credit Suisse's CL Position: Q1 2024 in Review

Credit Suisse reduced its Colgate-Palmolive (CL) stake by 8.5% in Q1 2024, selling an estimated $13.7M and leaving 1,747,123 shares worth $157M. The position accounts for 0.15% of the portfolio, ranked #117.

Credit Suisse first reported a position in CL in Q2 2013 and has held it in 44 quarters since. The position peaked at $217M in Q4 2021. 1,765 funds tracked by Wall St. Rank hold CL as of Q1 2024.

  • Credit Suisse held 1,747,123 shares of Colgate-Palmolive worth $157M as of Q1 2024.
  • Credit Suisse sold 162,164 Colgate-Palmolive shares in Q1 2024, an estimated $13.7M.
  • Colgate-Palmolive made up 0.15% of Credit Suisse's portfolio in Q1 2024, its #117 holding.
  • Credit Suisse first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Colgate-Palmolive position peaked at $217M in Q4 2021.
  • 1,765 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.